Ulmert et al. tested whether PSAV improved the accuracy of a model using PSA level to predict long-term risk of PCa diagnosis in 4907 screened men (of which 443 [9%] were diagnosed with PCa) [41]. The gene discussed is KLK3; the disease is posterior cortical atrophy.